Results 161 to 170 of about 34,947 (279)

Cardiac Magnetic Resonance to Define Myocardial Structure in Obesity-Associated Heart Failure. [PDF]

Curr Cardiol Rep
Cutts JA, Epstein FH, Patel AR.
europepmc   +1 more source

Implementation of an Integrated Pharmacology Curriculum in a Flipped, Small‐Group, Case‐Based, Pre‐Clerkship Medical Curriculum Improved Student Performance

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Rush Medical College implemented a new, integrated pre‐clerkship curriculum. Pharmacology was integrated with other basic sciences into a flipped, small‐group, case‐based structure. This report describes the main features of the pharmacology curriculum for pharmacology directors to have a template.
Brinda Desai Bradaric, Eric Van Rite, Lalita Prasad‐Reddy, Michael Bradaric   +3 more
wiley   +1 more source

Machine learning-based risk stratification identifies heart failure with preserved ejection fraction as an independent predictor of adverse outcomes in hypertrophic cardiomyopathy. [PDF]

Sci Rep
Zhang W, Zhao H, Tian Z, Fu W, Li Z, Geng Z, He Y, He H, Wu P, Zhu S, Yang M, Chen J, Lin M, Zhang Z, Wang M, Zhu Z, Cui Y, Piao F, Zheng M.   +18 more
europepmc   +1 more source

Focus on HFpEF in heart failure

Chinese Medical Journal, 2022
Chunhui He, Rongchong Huang, Ningning Wang   +2 more
openaire   +3 more sources

Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Mitiperstat is a novel myeloperoxidase inhibitor being investigated for the treatment of heart failure, metabolic dysfunction‐associated steatohepatitis, and chronic obstructive pulmonary disease. Pharmacokinetic data from five clinical trials were used to develop a mitiperstat population pharmacokinetics (popPK) model.
Mikael Sunnåker, Jacob Leander, Hans Ericsson   +2 more
wiley   +1 more source

Osteopontin in HFpEF

Journal of the American College of Cardiology, 2019
Fadi N. Salloum, Vinh Q. Chau
openaire   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Reframing obesity-related HFpEF as a multiorgan syndrome: incretin-based therapies and imaging endpoints. [PDF]

Heart Fail Rev
Mahmod M, Dennis A, Lian J, Langford C, Rahimi K, Wamil M.   +5 more
europepmc   +1 more source

Molecular Signature of HFpEF

JACC: Basic to Translational Science, 2021
Andrew A. Gibb, Emma K. Murray, Deborah M. Eaton, Anh T. Huynh, Dhanendra Tomar, Joanne F. Garbincius, Devin W. Kolmetzky, Remus M. Berretta, Markus Wallner, Steven R. Houser, John W. Elrod   +10 more
openaire   +1 more source

Strengths and limitations of HFpEF probability scores in the era of precision medicine. [PDF]

Front Med (Lausanne)
Wilk M, Kotwica T, Zymliński R, Gajewski P.   +3 more
europepmc   +1 more source